" class="no-js "lang="en-US"> Dr. Jacqueline Sneddon, BSAC, on Antibiotics
Friday, June 09, 2023

Dr. Jacqueline Sneddon, BSAC, on Antibiotics

At the 33rd ECCMID event, we caught up with Dr. Jacqueline Sneddon, the Programmes Manager of the British Society for Antimicrobial Chemotherapy (BSAC), as she discusses the important issue of antibiotics and antimicrobial stewardship. She highlights the increasing problem of antimicrobial resistance and the need for effective stewardship to ensure the continued effectiveness of antibiotics.

Sneddon emphasizes the importance of educating healthcare professionals and the general public about the appropriate use of antibiotics and the problem of antimicrobial resistance. She highlights the role of organizations like BSAC in promoting awareness and providing education and resources to support stewardship efforts.

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more